HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose methotrexate as a steroid-sparing agent in a child with Takayasu's arteritis.

Abstract
Takayasu's arteritis (TA) is a chronic inflammatory arteriopathy affecting the large vessels and has been described predominantly in young adult women. In children it presents as an aggressive disease usually requiring chronic corticosteroid therapy. At present, low dose oral methotrexate (MTX) appears to be an effective steroid-sparing agent in adult patients with active TA. We report a 4-year-old child with Takayasu's arteritis who was initially placed on oral prednisone (2 mg/kg/day) therapy. Three months later, low-dose oral MTX (10 mg/m2/week) was added. Prednisone was successfully tapered over the following year to 0.2 mg/kg every other day. A repeat angiography following 12 months of therapy revealed a dramatic improvement of the vascular lesions. No toxicity was observed with MTX therapy. In conclusion, low-dose oral MTX appeared to be an efficient, safe and steroid-sparing agent in the treatment of a young child with TA.
AuthorsA K Shetty, A R Stopa, A Gedalia
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 1998 May-Jun Vol. 16 Issue 3 Pg. 335-6 ISSN: 0392-856X [Print] Italy
PMID9631760 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Antirheumatic Agents
  • Methotrexate
Topics
  • Adrenal Cortex Hormones (adverse effects, blood)
  • Angiography
  • Antirheumatic Agents (administration & dosage)
  • Carotid Arteries (diagnostic imaging)
  • Child, Preschool
  • Humans
  • Male
  • Methotrexate (administration & dosage)
  • Subclavian Artery (diagnostic imaging)
  • Takayasu Arteritis (diagnostic imaging, drug therapy, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: